NCT05803200View on ClinicalTrials.gov

A Study to Describe Mothers' and Babies' Outcomes After Exposure to HyQvia During Pregnancy

CompletedOBSERVATIONAL

Enrollment

7

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

April 14, 2023

Study Completion Date

April 14, 2023

Conditions

Exposure During Pregnancy

Interventions

DRUG

No intervention

No intervention was given as this is an observational study.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY